Patent Assignment
Reel/Frame 063993/0240
Assignment of Assignor's Interest
Recorded: 2023-06-20
Pages: 6
Assignors
VAITKEVICIUS, HENRIKAS
Executed: 2023-06-14
GASIOR, MACIEJ
Executed: 2023-06-01
HULIHAN, JOSEPH
Executed: 2023-06-01
Assignee
MARINUS PHARMACEUTICALS, INC.
5 RADNOR CORPORATE CENTER, SUITE 500, 100 MATSONFORD ROAD, RADNOR, PENNSYLVANIA, 19087
Covered Property
(1)
Ganaxolone for Use in Treatment of Super Refractory Status Epilepticus
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Oct 28, 2022
From: MARINUS PHARMACEUTICALS, INC.
To: SAGARD HEALTHCARE ROYALTY PARTNERS, LP
Reel/Frame 061580/0171 →
Release of Security Interest
Feb 13, 2025
From: SAGARD HEALTHCARE PARTNERS FUNDING COMPANY SPE 1, LLC
To: MARINUS PHARMACEUTICALS, INC.
Reel/Frame 070204/0035 →
Change of Name
May 15, 2025
From: MARINUS PHARMACEUTICALS, INC.
To: IMMEDICA PHARMA US INC.
Reel/Frame 071128/0594 →